Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

TVF Communications

Ischemix names David DeWahl as CEO

He joins the US biotech from private investment firm Colchester Healthcare Investments

- PMLiVE

NHS failing to promote clinical trials to patients

NIHR mystery shoppers report says 91 per cent of sites have no information in reception area

- PMLiVE

Royal National Orthopaedic Hospital NHS Trust appoints Grayling

Agency brought in as hospital plans £84m improvement programme

- PMLiVE

Olympic gold medalist becomes face of Asthma UK

Cyclist Laura Trott is supporting the charity’s Facebook page

- PMLiVE

Gilead $1bn antibody deal with MacroGenics

Joins Boehringer and Servier in use of US biotech’s DART technology

- PMLiVE

FDA releases guidance on how to prevent abuse of opioid painkillers

Explains to companies best ways to make tamper-resistant drugs

- PMLiVE

FDA-approved iPhone heart monitor now available

AliveCor's device can initially only be bought by US healthcare professionals

- PMLiVE

Hikma expands in Egypt with EPCI acquisition

Deal in fast-growing North African market is worth about $22m

- PMLiVE

Evotec expands open innovation push with Yale deal

Takes aim at diseases with unmet medical need with academic partnership

Quintiles signs local bioanalytical deal for South Korea

Partners with Seoul-based contract research organisation BioCore

Gary Nabel to lead Sanofi’s strategy council

Pharma firm’s chief scientific officer replaces Richard Klausner

Robyn Cabarrao: ‘If I could change one thing…’

The Global Affiliate Liaison at inVentiv Health Communications/Europe explains what she would improve within the industry

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links